Home » Gilead Buys Calistoga Pharma for $375 Milion, Making Move Into Cancer Drugs
Gilead Buys Calistoga Pharma for $375 Milion, Making Move Into Cancer Drugs
Gilead Sciences is the world’s biggest maker of HIV medications, and today it’s making a big move to diversify into the cancer drug field by acquiring Seattle-based Calistoga Pharmaceuticals.
Xconomy
Xconomy
Upcoming Events
-
23Apr
-
25Apr
-
07May
-
14May
-
30May